Lower limb lymphedema
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Lower limb lymphedema
Exclusion criteria
Exclusion criteria: Use of topical antifungal and prophylactic antibiotics for secondary infections; infectious processes active and not treated during the project; thrombophlebitis; active neoplasms at the site of drainage, cellulitis, deep venous thrombosis in the acute phase, cardiac, hepatic and renal decompensations, and uncontrolled hypertension; significant lower limb arteriopathies and neoplastic degeneration of lymphedema.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A reduction in lower limb lymphedema, measured by centimeter perimeter at the end of the intervention, is expected. | — |
Secondary
| Measure | Time frame |
|---|---|
| An improvement in patients' quality of life is expected, using the short form of the Quality of Life Questionnaire - SF-36 as the evaluation method.;It is expected to increase the range of motion of the ankle joint as measured by goniometry. | — |
Countries
Brazil
Contacts
UFPE - Universidade Federal de Pernambuco;UFPE - Universidade Federal de Pernambuco